ANHX
gene geneOn this page
Summary
ANHX (anomalous homeobox, HGNC:40024) is a protein-coding gene on chromosome 12q24.33, encoding Anomalous homeobox protein (E9PGG2).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of skeletal muscle cell proliferation; regulation of transcription by RNA polymerase II; and skeletal muscle fiber development. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus.
Source: NCBI Gene 647589 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_001372060
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40024 |
| Approved symbol | ANHX |
| Name | anomalous homeobox |
| Location | 12q24.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000227059 |
| Ensembl biotype | protein_coding |
| Entrez | 647589 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000419717, ENST00000545940, ENST00000673940
RefSeq mRNA: 2 — MANE Select: NM_001372060
NM_001191054, NM_001372060
CCDS: CCDS53855, CCDS91786
Canonical transcript exons
ENST00000545940 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001617662 | 133226318 | 133226438 |
| ENSE00001622610 | 133235807 | 133235877 |
| ENSE00001648442 | 133218312 | 133218971 |
| ENSE00001653494 | 133231517 | 133231644 |
| ENSE00001656095 | 133226936 | 133227152 |
| ENSE00001674517 | 133227824 | 133227947 |
| ENSE00001718184 | 133219283 | 133219367 |
| ENSE00001734196 | 133234108 | 133234378 |
| ENSE00003896409 | 133225536 | 133225828 |
| ENSE00003897678 | 133221205 | 133221352 |
Expression profiles
Bgee: expression breadth broad, 50 present calls, max score 85.29.
Top tissues by expression
166 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.15 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 84.82 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 84.53 | silver quality |
| sperm | CL:0000019 | 84.26 | silver quality |
| endothelial cell | CL:0000115 | 84.04 | silver quality |
| mammary duct | UBERON:0001765 | 83.98 | silver quality |
| myocardium | UBERON:0002349 | 83.75 | silver quality |
| gingival epithelium | UBERON:0001949 | 83.16 | silver quality |
| vena cava | UBERON:0004087 | 81.40 | silver quality |
| ventral tegmental area | UBERON:0002691 | 80.56 | silver quality |
| esophagus squamous epithelium | UBERON:0006920 | 80.09 | gold quality |
| heart right ventricle | UBERON:0002080 | 79.81 | gold quality |
| cardia of stomach | UBERON:0001162 | 79.05 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 79.04 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 78.69 | silver quality |
| lower lobe of lung | UBERON:0008949 | 78.25 | silver quality |
| cerebellar vermis | UBERON:0004720 | 78.22 | silver quality |
| cartilage tissue | UBERON:0002418 | 78.21 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 78.15 | silver quality |
| body of tongue | UBERON:0011876 | 78.10 | silver quality |
| tongue | UBERON:0001723 | 77.90 | silver quality |
| decidua | UBERON:0002450 | 77.90 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 77.79 | silver quality |
| deltoid | UBERON:0001476 | 77.76 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 77.66 | silver quality |
| pericardium | UBERON:0002407 | 77.64 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 77.63 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 77.57 | silver quality |
| superior vestibular nucleus | UBERON:0007227 | 77.51 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting ANHX, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-4777-3P | 99.15 | 68.92 | 626 |
| HSA-MIR-942-3P | 98.81 | 69.04 | 876 |
| HSA-MIR-6728-3P | 98.63 | 67.63 | 1534 |
| HSA-MIR-599 | 98.32 | 66.99 | 1037 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-10395-3P | 98.10 | 66.70 | 1726 |
| HSA-MIR-506-5P | 98.02 | 67.41 | 1065 |
| HSA-MIR-3144-5P | 97.64 | 65.45 | 646 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-592 | 96.59 | 67.59 | 817 |
| HSA-MIR-6767-5P | 90.00 | 62.41 | 97 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | six4a | ENSDARG00000004695 |
| danio_rerio | six4b | ENSDARG00000031983 |
| danio_rerio | six7 | ENSDARG00000070107 |
| drosophila_melanogaster | Optix | FBGN0025360 |
| drosophila_melanogaster | Six4 | FBGN0027364 |
| caenorhabditis_elegans | WBGENE00000453 | |
| caenorhabditis_elegans | WBGENE00000455 | |
| caenorhabditis_elegans | WBGENE00006775 |
Paralogs (6): SIX4 (ENSG00000100625), SIX1 (ENSG00000126778), SIX3 (ENSG00000138083), SIX2 (ENSG00000170577), SIX5 (ENSG00000177045), SIX6 (ENSG00000184302)
Protein
Protein identifiers
Anomalous homeobox protein — E9PGG2 (reviewed: E9PGG2)
All UniProt accessions (3): E9PGG2, A0A669KBG6, A0A6E1YDD0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (2): NP_001177983, NP_001358989* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR008422 | KN_HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR031701 | SIX1_SD | Domain |
Pfam: PF05920, PF16878
UniProt features (7 total): sequence conflict 3, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E9PGG2-F1 | 68.30 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, chr12q24, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, SRC_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR6728_3P, MIR506_5P, MIR599, GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_PERTURB_ACCUMULATION_G1_S, PULVER_FOREY_PERTURB_ATTRITION_S, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of skeletal muscle cell proliferation (GO:0014857), skeletal muscle fiber development (GO:0048741), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (2): nucleus (GO:0005634), transcription regulator complex (GO:0005667)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| skeletal muscle cell proliferation | 1 |
| regulation of cell population proliferation | 1 |
| skeletal muscle tissue development | 1 |
| myotube cell development | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
374 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANHX | NANOGNB | Q7Z5D8 | 645 |
| ANHX | LRRC71 | Q8N4P6 | 567 |
| ANHX | ARGFX | A6NJG6 | 535 |
| ANHX | LEUTX | A8MZ59 | 531 |
| ANHX | DUXB | A0A1W2PPF3 | 513 |
| ANHX | TPRX1 | Q8N7U7 | 463 |
| ANHX | LYPD6B | Q8NI32 | 453 |
| ANHX | DUXA | A6NLW8 | 433 |
| ANHX | ZNF415 | Q09FC8 | 419 |
| ANHX | CLK4 | Q9HAZ1 | 418 |
| ANHX | DPRX | A6NFQ7 | 405 |
| ANHX | HOXB1 | P14653 | 384 |
| ANHX | DPPA3 | Q6W0C5 | 383 |
| ANHX | GDF3 | Q9NR23 | 381 |
| ANHX | IRX1 | P78414 | 379 |
IntAct
0 interactions, top by confidence:
BioGRID (1): IGF2R (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0J9YX94, A0A0J9YXQ4, A0A0J9YY54, A0A494C1R9, A5D7L8, A6NDY0, A6NKD2, A7E321, E9PGG2, F6SZT2, O14771, O19110, O75807, O88852, P0CV98, P0CV99, P0CW00, P0CW01, P0CW24, P17564, P78358, Q01534, Q0P5N2, Q15735, Q2KI51, Q2M329, Q587J8, Q5DTT8, Q5R5G8, Q5R6R8, Q5SV97, Q60465, Q62881, Q69ZB3, Q6P752, Q86V59, Q8BSI6, Q8IWY8, Q8N3D4, Q8VD63
Diamond homologs: E9PGG2, O42406, O93307, O95343, O95475, Q62233, Q94165, Q95RW8, Q9QZ28, A1YER0, A2D5H2, A6NDR6, A8K0S8, B3DM47, B4F6V6, O00470, O14770, O17894, O35317, O35984, O46339, O73916, P10842, P40424, P40425, P40426, P40427, P41778, P41779, P48731, P56661, P56662, P56666, P56667, P56668, P70178, P79937, P97367, P97368, Q15475
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1934 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:133225666:CAG:C | acceptor_gain | 1.0000 |
| 12:133225668:G:GC | acceptor_gain | 1.0000 |
| 12:133226439:C:CC | acceptor_gain | 1.0000 |
| 12:133234105:TACCT:T | donor_loss | 1.0000 |
| 12:133234107:C:A | donor_loss | 1.0000 |
| 12:133234109:T:TA | donor_gain | 1.0000 |
| 12:133234375:CACT:C | acceptor_gain | 1.0000 |
| 12:133234377:CT:C | acceptor_gain | 1.0000 |
| 12:133234379:C:CC | acceptor_gain | 1.0000 |
| 12:133225665:CCAG:C | acceptor_gain | 0.9900 |
| 12:133225667:A:T | acceptor_gain | 0.9900 |
| 12:133225668:G:C | acceptor_gain | 0.9900 |
| 12:133226435:TCCT:T | acceptor_gain | 0.9900 |
| 12:133226436:CCTC:C | acceptor_gain | 0.9900 |
| 12:133226437:CT:C | acceptor_gain | 0.9900 |
| 12:133227822:AC:A | donor_gain | 0.9900 |
| 12:133227823:CC:C | donor_gain | 0.9900 |
| 12:133227823:CCCT:C | donor_gain | 0.9900 |
| 12:133234106:A:AC | donor_gain | 0.9900 |
| 12:133234106:ACCT:A | donor_gain | 0.9900 |
| 12:133234107:C:CC | donor_gain | 0.9900 |
| 12:133234107:CCT:C | donor_gain | 0.9900 |
| 12:133234107:CCTC:C | donor_gain | 0.9900 |
| 12:133234374:CCACT:C | acceptor_gain | 0.9900 |
| 12:133234375:CACTC:C | acceptor_gain | 0.9900 |
| 12:133234376:ACT:A | acceptor_gain | 0.9900 |
| 12:133234376:ACTC:A | acceptor_loss | 0.9900 |
| 12:133234377:CTC:C | acceptor_gain | 0.9900 |
| 12:133234378:TC:T | acceptor_loss | 0.9900 |
| 12:133234378:TCT:T | acceptor_gain | 0.9900 |
AlphaMissense
3135 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:133227099:A:C | F185L | 0.998 |
| 12:133227099:A:T | F185L | 0.998 |
| 12:133227101:A:G | F185L | 0.998 |
| 12:133231531:G:C | F121L | 0.998 |
| 12:133231531:G:T | F121L | 0.998 |
| 12:133231533:A:G | F121L | 0.998 |
| 12:133227100:A:G | F185S | 0.995 |
| 12:133231522:C:A | R124S | 0.995 |
| 12:133231522:C:G | R124S | 0.995 |
| 12:133231602:A:G | W98R | 0.993 |
| 12:133231602:A:T | W98R | 0.993 |
| 12:133227104:A:G | W184R | 0.992 |
| 12:133227104:A:T | W184R | 0.992 |
| 12:133227093:A:C | N187K | 0.991 |
| 12:133227093:A:T | N187K | 0.991 |
| 12:133227145:A:G | L170S | 0.991 |
| 12:133231523:C:G | R124T | 0.991 |
| 12:133231600:C:A | W98C | 0.991 |
| 12:133231600:C:G | W98C | 0.991 |
| 12:133227863:G:C | F154L | 0.990 |
| 12:133227863:G:T | F154L | 0.990 |
| 12:133227865:A:G | F154L | 0.990 |
| 12:133231532:A:G | F121S | 0.990 |
| 12:133227100:A:C | F185C | 0.989 |
| 12:133231523:C:A | R124M | 0.989 |
| 12:133231532:A:C | F121C | 0.989 |
| 12:133231601:C:G | W98S | 0.988 |
| 12:133227086:G:T | R190S | 0.987 |
| 12:133227088:C:G | R189P | 0.987 |
| 12:133227102:C:A | W184C | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000065447 (12:133221497 G>C), RS1000118965 (12:133234316 G>A,C), RS1000137567 (12:133231618 C>T), RS1000154001 (12:133236441 T>C), RS1000276879 (12:133236649 G>A), RS1000349299 (12:133232107 T>A), RS1000365693 (12:133226169 G>C), RS1000580189 (12:133237370 A>G), RS1000859601 (12:133228065 A>G,T), RS1000892086 (12:133228349 G>A), RS1000932213 (12:133222560 C>T), RS1000961820 (12:133222518 C>A), RS1001046139 (12:133218152 C>CACACTGGAA), RS1001048200 (12:133218277 G>A), RS1001268018 (12:133222778 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_179 | Refractive error | 1.000000e-12 |
| GCST010396_116 | Gut microbiota (bacterial taxa, hurdle binary method) | 7.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.